Publications by authors named "Michael A Durante"

PRAME is a CUL2 ubiquitin ligase subunit that is normally expressed in the testis but becomes aberrantly overexpressed in many cancer types in association with aneuploidy and metastasis. Here, we show that PRAME is expressed predominantly in spermatogonia around the time of meiotic crossing-over in coordination with genes mediating DNA double strand break repair. Expression of PRAME in somatic cells upregulates pathways involved in meiosis, chromosome segregation and DNA repair, and it leads to increased DNA double strand breaks, telomere dysfunction and aneuploidy in neoplastic and non-neoplastic cells.

View Article and Find Full Text PDF

PRAME is a CUL2 ubiquitin ligase subunit that is normally expressed in the testis but becomes aberrantly overexpressed in many cancer types in association with aneuploidy and metastasis. Here, we show that PRAME is expressed predominantly in spermatogonia around the time of meiotic crossing-over in coordination with genes mediating DNA double strand break repair. Expression of PRAME in somatic cells upregulates pathways involved in meiosis, chromosome segregation and DNA repair, and it leads to increased DNA double strand breaks, telomere dysfunction and aneuploidy in neoplastic and non-neoplastic cells.

View Article and Find Full Text PDF

Retinoblastoma (Rb) is a deadly childhood eye cancer that is classically initiated by inactivation of the RB1 tumor suppressor. Clinical management continues to rely on nonspecific chemotherapeutic agents that are associated with treatment resistance and toxicity. Here, we analyzed 103 whole exomes, 20 whole transcriptomes, 5 single-cell transcriptomes, and 4 whole genomes from primary Rb tumors to identify previously unknown Rb dependencies.

View Article and Find Full Text PDF

We previously demonstrated that pan-HDAC inhibitors could limit escape from MEK inhibitor (MEKi) therapy in uveal melanoma (UM) through suppression of AKT and YAP/TAZ signaling. Here, we focused on the role of specific HDACs in therapy adaptation. Class 2 UM displayed higher expression of HDACs 1, 2, and 3 than Class 1, whereas HDACs 6, 8, and 11 were uniformly expressed.

View Article and Find Full Text PDF

Introduction: Gene expression profiling (GEP) is widely used for prognostication in patients with uveal melanoma (UM). Because biopsy tissue is limited, it is critical to obtain as much genomic information as possible from each sample. Combined application of both GEP and next-generation sequencing (NGS) allows for analysis of RNA and DNA from a single biopsy sample, offers additional prognostic information, and can potentially inform therapy selection.

View Article and Find Full Text PDF

Uveal melanoma (UM) is the most common primary intraocular malignancy in adults and leads to deadly metastases for which there is no approved treatment. Genetic events driving early tumor development are well-described, but those occurring later during metastatic progression remain poorly understood. We performed multiregional genomic sequencing on 22 tumors collected from two patients with widely metastatic UM who underwent rapid autopsy.

View Article and Find Full Text PDF
Article Synopsis
  • Scientists have made cool new tools that help study different parts of tumors by looking at tiny pieces of DNA and RNA.
  • They created a tool called Uphyloplot2 that makes it easier to see how different parts of a tumor are related using special graphs.
  • You can find and use Uphyloplot2 for free online to help understand tumors better!
View Article and Find Full Text PDF
Article Synopsis
  • Single-cell RNA sequencing (scRNA-seq) helps scientists study individual cells by looking at their gene activity.
  • Techniques like UMAP and tSNE make it easier to visualize and group these cells based on their similarities.
  • PieParty is a new tool that changes how we see this data, using pie charts for each cell to show information about multiple genes at once, making it easier to understand.
View Article and Find Full Text PDF

Objectives: Mesenchymal stem cells (MSCs), classically expanded in culture from bone marrow, are of broad interest to the regenerative medicine community. Human nasal turbinate mesenchymal-like stem cell cultures have also been described, defined by an in vitro phenotype similar to bone marrow MSCs. Nonetheless, the identity in vivo of the cells that give rise to nasal MSC-like cultures remains unclear, and these cells are often suggested to be related to olfactory lineages.

View Article and Find Full Text PDF
Article Synopsis
  • Scientists are studying how certain heart cells, called cardiac progenitors (CPCs), behave after babies are born.
  • Most of these CPCs stop working during early heart development, but some special cells called cardiac neural crest cells (CNCs) keep making new heart cells even after birth.
  • However, while these CNCs can make heart cells, they don't multiply as much as they did before, which means the heart might not be able to heal itself as well as when we are younger.
View Article and Find Full Text PDF

The presence of active neurogenic niches in adult humans is controversial. We focused attention to the human olfactory neuroepithelium, an extracranial site supplying input to the olfactory bulbs of the brain. Using single-cell RNA sequencing analyzing 28,726 cells, we identified neural stem cell and neural progenitor cell pools and neurons.

View Article and Find Full Text PDF
Article Synopsis
  • Uveal melanoma (UM) is a serious type of cancer that doesn’t respond well to some new treatments called checkpoint immunotherapy.
  • Scientists studied a lot of cells from UM tumors to learn more about how they work and found lots of different types of immune cells in the tumors.
  • They discovered that a specific immune marker called LAG3 might be important for treating patients with a higher risk of UM in the future.
View Article and Find Full Text PDF

Importance: There has been speculation on the pathogenesis of unilateral multifocal uveal melanoma, but there remains no convincing explanation. Genetic analysis suggests that unilateral multifocal uveal melanoma may represent intraocular metastasis with increased risk of systemic metastasis.

Objective: To evaluate the pathogenesis of unilateral multifocal uveal melanoma.

View Article and Find Full Text PDF

The BAP1 tumor suppressor is mutated in many human cancers such as uveal melanoma, leading to poor patient outcome. It remains unclear how BAP1 functions in normal biology or how its loss promotes cancer progression. Here, we show that Bap1 is critical for commitment to ectoderm, mesoderm, and neural crest lineages during development.

View Article and Find Full Text PDF
Article Synopsis
  • The study highlights the challenge of resistance to MEK inhibitors in treating uveal melanoma and identifies the pan-HDAC inhibitor panobinostat as a potential solution.
  • The research reveals several escape pathways activated in melanoma cells post MEK inhibition, including the PI3K/AKT pathway and GPCR signaling, which contribute to treatment resistance.
  • Combining MEK inhibitors with HDAC inhibitors showed superior tumor growth reduction in various models, suggesting this combination could enhance treatment efficacy for advanced uveal melanoma.
View Article and Find Full Text PDF

Ocular melanocytosis is the most important predisposing condition for the eye cancer uveal melanoma (UM). Here, we present a patient who developed UM arising within ocular melanocytosis who was treated with enucleation (eye removal), which provided an invaluable opportunity to interrogate both the UM and adjacent uveal tissue containing the melanocytosis using whole-exome and deep-targeted sequencing. This analysis revealed a clonal mutation in the melanocytosis, confirming that this is indeed a neoplastic condition and explaining why it predisposes to UM.

View Article and Find Full Text PDF
Article Synopsis
  • Glioblastoma (GBM) is a serious brain tumor that mainly affects adults, and patients typically live around 14 months after diagnosis.
  • Scientists have created a new tool called SynergySeq to find the best combinations of existing drugs to treat GBM, using genetic data to help them.
  • By looking at how genes behave in GBM patients and combining this with drug information, researchers hope to discover new ways to help treat this tough disease in the future.
View Article and Find Full Text PDF
Article Synopsis
  • Cancer develops through genomic changes influenced by natural selection, but the timing of changes associated with metastasis is unclear.
  • Uveal melanoma (UM), the most common eye cancer, often leads to metastatic death linked to BAP1 mutations and is ideal for studying how tumors evolve.
  • Analysis of 151 UM samples revealed that BAP1 mutations occur early in tumor development, suggesting that a tumor’s potential to spread is determined early, explaining why treatment advancements haven't improved survival rates.
View Article and Find Full Text PDF

Additional Sex Combs-Like 1 () is mutated at a high frequency in all forms of myeloid malignancies associated with poor prognosis. We generated a promoter-driven transgenic mouse model, Tg, to express a truncated FLAG-ASXL1 protein in the hematopoietic system. The Tg mice had an enlarged hematopoietic stem cell (HSC) pool, shortened survival, and predisposition to a spectrum of myeloid malignancies, thereby recapitulating the characteristics of myeloid malignancy patients with mutations.

View Article and Find Full Text PDF

Background: We previously identified PRAME as a biomarker for metastatic risk in Class 1 uveal melanomas. In this study, we sought to define a threshold value for positive PRAME expression (PRAME+) in a large dataset, identify factors associated with PRAME expression, evaluate the prognostic value of PRAME in Class 2 uveal melanomas, and determine whether PRAME expression is associated with aberrant hypomethylation of the PRAME promoter.

Results: Among 678 samples analyzed by qPCR, 498 (73.

View Article and Find Full Text PDF